Products in stock in the United States can be delivered within 2 days.

+1-2404726069 (U.S.) +86-027-65528241 (Outside U.S.) overseas@yeasen.com shop website:https://yeabio.com
Order Center
0
 Sign In
Time
-

NEWS

NEWS

Low dsRNA T7 RNA Polymerase-a game-changer for the mRNA in vitro synthesis raw material industry.

Breakthrough Achievement from Yeasen and Molefuture biotechnology

2024-04-17

Yeasen's stars products shine brightly at Medlab 2024!

On February 5, 2024, Medlab Middle East 2024 opened grandly at the Dubai World Trade Center. Yeasen made a shining debut with its star products (booth number #Z2.J03), attracting many visitors to our booth to learn about the products and gain recognition from customers and the market.

2024-02-08

An invitation letter-Meet Yeasen at MEDLAB Middle East 2024 in Dubai

Welcome to visit us to explore our comprehensive product lines.

2024-01-29

A Remarkable Breakthrough in Strand-specific RNA Library Preparation

The incorporation of actinomycin D in RNA library constructing kits has undeniably improved the construction of strand-specific libraries, significantly enhancing chain specificity. This innovation has streamlined the experimental process, simplifying it for researchers. Moreover, it has substantially improved chain specificity, a pivotal aspect of RNA-related scientific inquiries.

2023-11-07

Yeasen：Distributors Wanted

Invite everyone to join our distributors and explore the local market.If you are interested in collaborating with us,please contact us immediately!

2023-11-03

Introduction Quality Control Strategies for Biological Products

Impurity residues and contaminants involved in the production process of biologics have a significant impact on the safety and efficacy of the final product and are strictly regulated by the drug regulatory authorities of various countries. Therefore, Yeasen Biotechnology has independently developed a series of biologics quality and safety control products for the detection of host cell DNA residues, nuclease residues, replicative lentivirus, viral vector copy number and mycoplasma contamination.

2023-09-19

Host Cell Residual DNA Detection Aids Biologics R&D and Manufacturing

Host cell residual DNA is a process-related impurity involved in the production of biologics, which not only reduces the effectiveness of biologics, but also may pose safety concerns such as infectiousness or tumorigenicity. Therefore, regulatory agencies in various countries have set limits on the amount of residual DNA in biologics.

2023-09-19

Yeasen attracted lots of attention in AACC 2023

Attention

2023-07-28

Special offer up to 50% off

First order for Special offer up to 50% off

2023-05-15

Overseas exhibitions | Yeasen will meet you at the World Vaccine Congress in Washington

2023-04-06